Larvol Delta - Caliway-Announces-US-FDA-IND-Clearance-for-CBL0302-Its-Second-Global-Pivotal-Phase-3-Study-of-CBL514

CBL-514 - Caliway Biopharmaceuticals

https://www.prnewswire.com/news-releases/caliway-announces-us-fda-ind-clearance-for-cbl-0302-its-second-global-pivotal-phase-3-study-of-cbl-514-302779938.html

May 22, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next